| 20 Janvier 2014
20 January 2014 - On 16 January 2014, the National Health and Family Planning Commission of China notified WHO of seven additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus.
Details of the cases are as follows:
- A 38 year old man, reportedly from Guizhou Province, who was working in Wenzhou City, Zhejiang Province, and then returned to Guizhou Province on 3 January. He was admitted to hospital on 8 January and died on 9 January. Investigation on when and where he became ill are continuing.
- A 59 year old man from Guangzhou City, Guangdong Province, who became ill on 6 January and was admitted to hospital on 13 January. He is currently in a serious condition.
- A 20 year old woman from Hangzhou City, Zhejiang Province, who became ill on 7 January and was admitted to hospital on 11 January and then transferred to another hospital on 14 January. She is currently in a critical condition. The patient has a history of exposure to poultry.
- A 58 year old man from Taizhou City, Zhejiang Province, who became ill on 7 January and was admitted to hospital on 14 January. He is currently in a critical condition. The patient has a history of exposure to poultry.
- A 30 year old man from Quanzhou City, Fujian Province, who became ill on 9 January and was admitted to hospital on 14 January. He is currently in a critical condition.
- A 60 year old man from Quanzhou City, Fujian Province, who became ill on 10 January and was admitted to hospital on 13 January. He is currently in a serious condition. The patient has a history of exposure to a live poultry market.
- A 76 year old woman from Foshan City, Guangdong Province, who became ill on 12 January and was admitted to hospital on the same day. She is currently in a critical condition.
The source of infection is still under investigation. So far, there is no evidence of sustained human-to-human transmission.
The Chinese government continues to take the following measures:
- strengthen surveillance and situation analysis;
- reinforce case management and treatment;
- conduct risk communication with the public and release information;
- strengthen international collaboration and communication; and
- conduct scientific studies.
WHO does not advise special screening at points of entry with regard to this event, nor does it currently recommend any travel or trade restrictions
